Pulmonary nodule diagnosis marker and application
A lung nodule, PLA2G6 technology, applied in the field of biotechnology detection, can solve problems such as difficult to distinguish, and achieve good clinical application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0045] Example 1 The mRNA levels of PTGER4, AKR1C1, PLA2G6, LTA4H, PLA2G7 and AKR1C3 were significantly increased in the diseased lung tissue of patients with pulmonary sarcoidosis
[0046] 1) Obtain lung tissue samples (n=35, 48 and 21) from pulmonary tuberculosis patients (TB), lung adenocarcinoma patients (AD) and pulmonary sarcoidosis (SA) patients to be tested, and use the lung adenocarcinoma patients' Paracancerous normal tissue served as a normal lung tissue control (NC; n=40).
[0047] 2) Lung tissue samples were ground, mRNA was extracted and purified using RNeasy Plus Mini Kit (Qiagen), and then used III1st Strand cDNA Synthesis SuperMix (Yeasen) kit was reverse transcribed to generate cDNA.
[0048] 3) Using the Applied Biosystems 7500 Real-Time PCR system, qPCR was used to analyze the above cDNA samples, and the mRNA levels of PLA2G6, PLA2G7, AKR1C1, AKR1C3, LTA4H and PTGER4 were detected. ACTB and 18S rRNA were used as internal reference genes. The primers used a
Example Embodiment
[0056] The preparation and use of embodiment 2 detection kit
[0057] The nucleotide sequences shown in Table 1 were synthesized and used as primers for amplifying internal reference genes and markers.
[0058] For convenience, the kit can also contain a control: cDNA sequences of normal human lung tissue samples.
[0059] The method of using the kit is as follows: taking a lung tissue sample from the subject, extracting RNA from the lung tissue sample using conventional methods (or using a specific kit), using the reagents in the detection kit, and using the normal lung tissue sample in the kit The cDNA sequence of SEQ ID NO. 1 to 6 was used as the control cDNA in the quantitative detection of Real-Time PCR, and the relative expression changes of at least one gene in the lung tissue of the subjects were detected.
[0060] The expression level of PLA2G6 is more than 2.851 times that of the control, or the expression level of PLA2G7 is more than 3.347 times that of the control, o
Example Embodiment
[0061] The application of embodiment 3 markers in clinical diagnosis
[0062] According to the method of Example 1, multiple subjects were tested respectively, and the test results were compared with current diagnostic methods (such as blood test, sarcoidosis antigen test, biopsy, lung X-ray, chest computed tomography) scan, etc.) to compare the results. The results show that the diagnostic results obtained by using the diagnostic markers of the present application are consistent with the pathological diagnostic results.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap